Insider trades
Andrew J. Fromkin, Director of Immunovant IMVT, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $8M. The latest trade was on 05/28.
Andrew J. Fromkin
Director
- Company
- Immunovant IMVT
- First filing
- 23/04/14
- Trades
- 25 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$8M
- Last trade
- 05/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
IMVT | Open-market sale | 05/28 | 05/29 | 221,951 sh2 trades | $33.51avg. | $7,438,111.2 | −74.9% |
IMVT | Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 22,249 sh2 trades | $23.25avg. | $517,189.24 | −20.6% |
IMVT | Open-market sale10b5-1 plan | 25/03/07 | 25/03/11 | 8,000 sh2 trades | $19.60avg. | $156,768.96 | −8.0% |
IMVT | Open-market sale10b5-1 plan | 23/12/01 | 23/12/05 | 12,350 sh3 trades | $39.73avg. | $490,696.72 | −12.2% |